机译:食品和药品管理局的诉讼程序公共研讨会血液安全减少技术2018(评论,第3026页)(评论,第3026页)
US Food and Drug Administration Center for Biologics Evaluation and ResearchOffice of Blood;
National Heart Lung and Blood InstituteBethesda Maryland USA;
Vitalant Research InstituteSan Francisco California;
Blood BankYale‐New Haven HospitalNew Haven Connecticut;
Blood BankYale‐New Haven HospitalNew Haven Connecticut;
Department of Pathology and Laboratory MedicineYale School of MedicineNew Haven Connecticut;
Department of PathologyDartmouth‐Hitchcock Medical CenterLebanon New Hampshire;
Department of Transfusion MedicineNIH Clinical CenterBethesda Maryland;
Blood ComponentsAmerican Red CrossRockville Maryland;
Department of Lab Medicine and PathologyUniversity of Minnesota Medical CenterMinneapolis Minnesota;
Department of Lab Medicine and PathologyUniversity of Minnesota Medical CenterMinneapolis Minnesota;
Vitalant Research InstituteSan Francisco California;
Department of Microbiology Immunology and PathologyColorado State UniversityFort Collins Colorado;
Cerus CorporationConcord California;
R&
DTerumoBCT Inc.Lakewood Colorado;
Hoxworth Blood CenterUniversity of Cincinnati HealthCincinnati Ohio;
Blood ComponentsAmerican Red CrossRockville Maryland;
The Robertson Trust Laboratory for Electronic Sterilisation Technologies (ROLEST)University of;
Department of HematologyCenter for Biologics Evaluation and Research US Food and Drug;
U.S. Army Institute of Surgical ResearchSan Antonio Texas;
Blood BankJohns Hopkins HospitalBaltimore Maryland;
机译:食品和药品管理局的诉讼程序公共研讨会血液安全减少技术2018(评论,第3026页)(评论,第3026页)
机译:2016年新红细胞产品监管科学粮食和药物管理局公共研讨会的诉讼程序
机译:朝向血资供应的通用病原体减少(会议报告,第3002页)(会议报告,第3002页)
机译:美国食品药品管理局(FDA)2016年新红细胞产品监管科学公开研讨会论文集
机译:血液安全病原体减少技术的食品和药品管理局公共研讨会(评论,第3026页)